跳至主要内容
临床试验/NCT02663492
NCT02663492Unknown不适用

Transcutaneous Electrical Acupoint Stimulation Ameliorates Chemotherapy-Induced Bone Marrow Suppression in Lung Cancer Patients

Tongji University1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2014年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
300
试验地点
1
主要终点
Change of Blood routine indexes in 1 month

研究概览

简要总结

To investigate the effect of percutaneous electrical stimulation on chemotherapy-induced bone marrow suppression in patients with lung cancer.

详细描述

Lung cancer is the malignant neoplasm with the highest incidence and mortality in China as well as worldwide. Non-small cell lung cancer (NSCLC) accounts for 80%-85% of all lung cancer cases. Chemotherapy is the preferred treatment method for NSCLC, but many patients cannot tolerate the adverse reactions of chemotherapy. Among the most common and most severe adverse reactions is bone marrow suppression. The more serious the bone marrow suppression, the higher the direct medical cost of chemotherapy. Literatures showed Acupuncture was used to treat patients with chemotherapy-induced bone marrow suppression. In this study, the effect of percutaneous electrical stimulation of acupoints including Dazhui (DU14), Geshu (BL17), Zusanli (ST36), Sanyinjiao (SP6), and Hegu (LI4) will be investigated, compared with the medication group treated by oral administration of prophylactic agents, and the control group received routine nursing care on chemotherapy-induced bone marrow suppression in patients with lung cancer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis of Non-small cell lung cancer(NSCLC)
  • age between 20 and 75 years
  • chemotherapy naive after diagnosis
  • GP regimen as treatment
  • an expected survival of more than 12 weeks based on a score equal to or greater than 60 points on Karnofsky performance status (KPS) scale
  • the ability to understand and speak Mandarin

排除标准

  • diagnosis of a hematological system tumor
  • mental illness
  • bone marrow suppression prior to chemotherapy
  • pregnancy

研究组 & 干预措施

TEAS group

Experimental

Patients with transcutaneous electrical acupoint stimulation (TEAS) group receive electrical stimulation of acupoints including Dazhui (DU14), Geshu (BL17), Zusanli (ST36), Sanyinjiao (SP6), and Hegu (LI4).

干预措施: TEAS (Device)

Medication group

Active Comparator

On the basis of routine nursing care, patients need to take Sanguisorba officinalis L., named Diyu Shengbai Pian (a Traditional Chinese Medicine) 3 times per day.

干预措施: Sanguisorba officinalis L. (Drug)

结局指标

主要结局

Change of Blood routine indexes in 1 month

时间窗: Day 0, Day 5, Day 8, Day 11, Day 14, Day 21 and Day 28

The routine blood examinations of indicators of bone marrow suppression, including red blood cells (10\^12/L), hemoglobin (g/L), white blood cells (10\^9/L), and platelets (10\^9/L).

次要结局

  • Change of Comfort Degree(Day 0, Day 8, and Day 28)

研究者

发起方
Tongji University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Caicun Zhou

Director

Tongji University

研究点 (1)

Loading locations...

相似试验

Transcutaneous Electrical Acupoint Stimulation for... | 临床试验